Development, validation, and clinical utility of a novel methylation classifier for recurrence risk prediction in meningiomas [dataset 1]
GSE292325Duckett et al., 2025
Overview
- Modality
- DNA methylation (array)
- Sample count
- 186
- Patient count
- Not reported
- Institution
- Northwestern Medicine
- Corresponding author
- Madina Sukhanova, Pouya Jamshidi
- Platform
- GPL23976
- Access type
- open
- Tissue preservation
- ffpe
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- G1: 83 G2: 89 G3: 14
- Sex distribution
- 131 female, 55 male (n=186, extracted from GSM 'sex' field)
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
WHO grade breakdown availableLarge cohort (top quartile)Primary vs. recurrent annotatedMolecular subtype annotatedOutcome/survival dataPeer-reviewed
Publications
- Duckett D, et al. Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas. Acta neuropathologica communications, 2025. PMID 41466325 · DOI
Related datasets
Also related: GSE292326, GSE292327